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to have Chagas disease in 2011, 
giving a London-wide prevalence 
of 1·27%. The numbers of expected 
cases of Chagas disease were highest 
in Lambeth (n=133) and Southwark 
(n=198). Four other boroughs were 
predicted to have between 50 and 
100 cases of Chagas disease (ﬁ gure).
Although Brazi l ,  Colombia, 
Guyana, and Ecuador contributed the 
largest migrant populations, higher 
prevalence in Bolivia meant that the 
predicted estimate of Chagas disease 
was highest in these migrants (table). 
In descending order of prevelance, 
Brazilian, Argentinian, Colombian, and 
Mexican migrants also contributed 
notably to the total predicted burden 
in London.
The total number of reported cases of 
T cruzi infection diagnosed in London 
from 2001 to 2014 was 41 (Allen J, 
Hospital for Tropical Diseases, personal 
communication), giving a prevalence 
among Latin American migrants in 
London of 0·043%. The rate ratio 
between the observed and the 
Addressing the neglect: 
Chagas disease in 
London, UK 
Chagas disease is an emerging but 
still largely unrecognised infectious 
parasitic disease in European 
countries.1 It has important public 
health implications because, 
although the classic vector-borne 
route of transmission only occurs in 
endemic areas of Latin America, the 
less common transmission routes—
blood transfusion, transplantation, 
and vertical transmission from 
mother to child—have been shown in 
Europe.2 Therefore, providing policy 
makers with accurate estimates of 
country-speciﬁ c prevalence of Chagas 
disease should inform the design 
and implementation of the most 
cost-effective health interventions.3 
We used demographic data from 
London, UK, and Trypanosoma cruzi 
seroprevalence data from source 
countries to generate high-resolution 
estimates of the burden of undetected 
T cruzi infection in London, and 
compared these estimates with the 
actual number of cases reported. 
The number of residents in London 
who were originally from the 
21 endemic countries in Central and 
South America was calculated from 
the 2011 UK National Census4 and 
was stratified by borough. We did 
not include undocumented migrants 
and individuals born to mothers from 
endemic Latin American countries. 
To calculate the expected number of 
people infected with T cruzi, the number 
of migrants from each country of origin 
was multiplied by that country’s speciﬁ c 
Chagas disease prevalence among 
migrants living in Europe, as estimated 
in a meta-analysis.3 For endemic Latin 
American countries without data in 
the meta-analysis, the prevalence was 
obtained from a report based on 2010 
estimates of Chagas disease in Latin 
America.5 The minimum and maximum 
prevalence estimates for countries in 
the meta-analysis were derived from 
the 95% CIs. Finally, the total expected 
number of cases was divided by the 
total Latin American population living 
in each London borough. 
The actual number of diagnosed 
cases of Chagas disease in London 
registered from Jan 1, 2001, to Sept 30, 
2014, was derived from the number of 
positive serological tests reported by 
the UK National Parasitology Reference 
Laboratory, where all UK serological 
testing for this disease is done. To 
estimate the index of underdiagnosis, 
we calculated the rate ratio between 
observed and expected prevalence 
(ie, the proportion of diagnosed cases 
divided by the total estimated cases). 
The index was calculated as 1–rate ratio.
We estimated that 95 579 indi-
viduals originally from the 21 T cruzi 
endemic countries of Central and 
South America were living in London 
in 2011.4 Lambeth, Southwark, 
Wandsworth, and Brent were the 
boroughs with the largest Latin 
American migrant populations 
(ﬁ gure). 1211 migrants were estimated 
Figure: Spatial distribution of Latin American migrants and estimated Chagas disease cases in boroughs 
of London, 20114
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UK, although these strategies are 
recommended by WHO because of high 
treatment eﬃ  cacy.10 Implementation 
of Chagas disease screening strategies 
in antenatal care programmes in 
London, where half of all Latin 
American migrants in the UK reside, 
should be urgently considered by 
policy makers. Integration into existing 
antenatal screening programmes for 
other infectious diseases (eg, HIV and 
syphilis) or haemoglobinopathies 
(for which data on country of origin 
are already collected) could facilitate 
uptake by antenatal units. 
To be cost-effective, screening 
should be limited to people from 
countries likely to yield the most cases. 
We found that Bolivian migrants had 
the highest burden of infection despite 
the number of residents in London 
not being high. Argentina, Brazil, and 
Colombia were also associated with 
high predicted numbers of Chagas 
disease cases in London. Moreover, 
eﬀ orts to promote screening should 
target those for whom screening could 
be most beneﬁ cial, such as pregnant 
Latin American women or those of 
childbearing age. Finally, prioritising 
screening in boroughs of London with 
the largest burdens of underdiagnosis 
should deliver the greatest yields on 
time and resources invested. 
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Estimation of the real size of the 
Latin America migrant population 
is constrained by the use of official 
data. Accordingly, our analysis did not 
include irregular migrants or second-
generation Latin American migrants in 
London. If these groups are included, 
we estimate (albeit crudely) that 
133 500 Latin American migrants 
would have been in London in 2011.9 
Inclusion of second-generation Latin 
American migrants might be useful 
because they could have been exposed 
to T cruzi through vertical transmission 
without ever having travelled to Latin 
America. Another group to consider is 
Latin America migrants who have been 
granted citizenship in other European 
countries and, therefore, might no 
longer be identiﬁ able as being of Latin 
America origin.9 
Antenatal screening for and 
treatment of vertically infected 
neonates are not being done in the 
expected prevalence of T cruzi infection 
was 3·34%, resulting in an index of 
underdiagnosis of 96·6%.
On the basis of epidemiological and 
demographic predictions, the estimated 
Chagas disease prevalence among 
Latin American migrants exceeds 
1%. However, with only 41 reported 
cases, this finding would mean that 
more than 1000 people in London are 
unknowingly infected with T cruzi. The 
level of underdiagnosis is very high,6 
although the proportion is similar to 
those other non-endemic countries.1,7 
Despite the increase in the number 
of people arriving in London from 
endemic countries each year, studies 
of Chagas disease and the health 
status of Latin America migrants are 
scarce.8 Thus, health-care providers’ 
knowledge of this disease might not be 
proportionate to the increasing chance 
that they could unknowingly encounter 
infected patients. 
Number of migrants Expected cases (range*) Estimated prevalence†
Argentina 4567 100 (37–189) 2·2%
Belize 212 1 0·3%
Bolivia 2694 485 (374–610) 18·0%
Brazil 31 357 188 (50–351) 0·6%
Chile 2913 29 (5–69) 1·0%
Colombia 19 338 97 (29–178) 0·5%
Costa Rica 254 0 0·2%
Ecuador 7171 29 (13–52) 0·4%
El Salvador 364 36 (6–43) 3·7%
French Guiana 121 1 0·8%
Guatemala 305 4 1·2%
Guyana 13 798 116 0·8%
Honduras 164 7 (2–12) 4·2%
Mexico 3785 57 (9–142) 1·5%
Nicaragua 154 7 (1–17) 4·6%
Panama 229 1 0·5%
Paraguay 287 16 (10–23) 5·5%
Peru 3301 20 (8–39) 0·6%
Suriname 203 2 0·8%
Uruguay 540 4 (0–12) 0·8%
Venezuela 3822 34 (6–85) 0·9%
Total 95 579 1211 1·3%
*Minimum and maximum values could be derived from 95% CIs in the meta-analysis but not the 2010 report. 
†Based on a meta-analysis3 and a report of Chagas disease prevalence in Latin America in 2010.5 
Table: Expected prevalence of Chagas disease in London in 2011, by country of origin
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